Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ATG-022 |
Trade Name | |
Synonyms | ATG 022|ATG022 |
Drug Descriptions |
ATG-022 is an antibody-drug conjugate (ADC) targeting CLDN18.2, which potentially inhibits tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 1143). |
DrugClasses | CLDN18.2 Antibody 18 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATG-022 | ATG-022 | 0 | 1 |